Liquid biopsy promised a simpler path to early detection and monitoring — but the workflow behind it stayed stubbornly manual. Sample prep alone spans 50+ hands-on steps, and every one of them introduces variability that compounds by the time a result reaches a clinician.
A decade of microfluidics and nucleic-acid research at the University of Virginia became the foundation for Avant Source™ — an enclosed fluidic cartridge and benchtop instrument that collapses that workflow into two steps: load the sample, remove the cartridge.
Our mission is to democratize access to precision oncology by making blood-based cancer detection faster, more inexpensive, and more reliable — starting with automated liquid biopsy sample preparation.